Healthcare – Feedback


Tata Trusts today said it has set up an ‘Impact Lab’ at IIT Delhi in partnership with health innovation player PATH for healthcare solutions in areas such as maternal and child health, nutrition and diagnostics for chronic and infectious diseases, among others. Collaboration between the two will mobilise about USD 10 million to run the […]

Maharashtra’s mine workers who face an increased risk of tuberculosis will be part of awareness programmes on the illness, as part of a partnership that the Maharashtra Government recently formalized with Johnson & Johnson. Other interventions under the ambit of the agreement include hospital acquired infections and maternal and infant mortality, a J&J note said. […]

Merck Foundation (MF), a non-profit company and subsidiary of Merck KGaA Germany, and the University of Malaya (UM), Malaysia’s oldest and most established institution of higher learning, signed a Memorandum of Understanding (MoU) recently to provide fellowship training for post-graduate medical trainees from Africa and other developing countries. Over 30,000 medical graduates from more than […]

Tata Memorial Centre in collaboration with Tata Institute of Social Sciences and supported by Tata Trusts, has introduced Kevat- an advanced diploma in patient navigation which is a specialized academic programme in cancer-care. This course is one of the first in India to focus on an emerging patient navigation model that can be applied across […]

Tata showing interst in Healthcare resaerch in partnership with Council of Scientific and Industrial Research (CSIR). Ratan Tata, the chairman emeritus of Tata Sons, and Google India’s managing director Rajan Anandan are among a group of investors backing the Bombay Hemp Company (Boheco), the first startup in the country to study the medical use of […]

Bharat Biotech’s Typbar TCV, the Typhoid Conjugate Vaccine against typhoid fever has received prequalification from World Health Organisation (WHO). This enables the procurement and supplies to UNICEF, Pan-American Health Organization (PAHO) and GAVI supported countries. The company stated that as the world’s first clinically proven Typbar TCV has been evaluated in Human Challenge Studies at […]

Drug firm Vivimed Labs today said it has received additional investment of USD 7.5 million (over Rs.47 crore) from healthcare investment firm OrbiMed Asia in its subsidiary Vivimed Labs (Mascarene). Company had earlier received USD 42.5 million from OrbiMed Asia in September 2017, Vivimed Labs said in a BSE filing. Overseas subsidiary is the holding […]